Vicente Estrada

Summary

Country: Spain

Publications

  1. ncbi request reprint Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial
    Ana Barrios
    Department of Infectious Diseases, Hospital Carlos III, Madrid
    Antivir Ther 10:825-32. 2005
  2. pmc Partners of people on ART - a New Evaluation of the Risks (The PARTNER study): design and methods
    Alison Rodger
    Research Department of Infection and Population Health, University College London, London, UK
    BMC Public Health 12:296. 2012
  3. pmc Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort
    Vicente Estrada
    Hospital Clinico San Carlos, Madrid, Spain
    BMC Womens Health 11:36. 2011
  4. ncbi request reprint Dyslipidemia related to antiretroviral therapy
    Vicente Estrada
    Department of Infectious Diseases, Hospital Clinico San Carlos, Madrid, Spain
    AIDS Rev 13:49-56. 2011
  5. doi request reprint [Etravirine drug interactions]
    Vicente Estrada Pérez
    Hospital Clinico San Carlos, Madrid, Espana
    Enferm Infecc Microbiol Clin 27:27-31. 2009
  6. doi request reprint [Clinical factors and biomarkers associated with subclinical atherosclerosis in the human immunodeficiency virus infection]
    Sergio Serrano-Villar
    Servicio de Medicina Interna III, Hospital Clinico San Carlos, Madrid, Espana
    Med Clin (Barc) 139:231-7. 2012
  7. ncbi request reprint Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study
    Matilde Sanchez-Conde
    Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain
    AIDS Res Hum Retroviruses 23:1237-41. 2007
  8. doi request reprint Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms
    Sergio Serrano-Villar
    Department of Internal Medicine, Hospital Clinico San Carlos, Madrid, Spain
    Eur J Prev Cardiol 21:739-48. 2014
  9. ncbi request reprint Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy
    Vicente Estrada
    Internal Medicine Department, Diabetes and Lipids Research Laboratory, Hospital Clinico San Carlos, Complutense University, 28040 Madrid, Spain
    Metabolism 55:940-5. 2006
  10. doi request reprint Association of HIV-Infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosis
    Dulcenombre Gomez-Garre
    Vascular Biology Research Laboratory, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos IdISSC, Madrid, Spain
    J Acquir Immune Defic Syndr 61:545-51. 2012

Detail Information

Publications27

  1. ncbi request reprint Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial
    Ana Barrios
    Department of Infectious Diseases, Hospital Carlos III, Madrid
    Antivir Ther 10:825-32. 2005
    ..Patients with grade 4 toxicities or plasma HIV-1 RNA values repeatedly >1000 copies/ml discontinued the study...
  2. pmc Partners of people on ART - a New Evaluation of the Risks (The PARTNER study): design and methods
    Alison Rodger
    Research Department of Infection and Population Health, University College London, London, UK
    BMC Public Health 12:296. 2012
    ..There are no data on risk of transmission for anal sex in MSM when the index partner is on ART...
  3. pmc Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort
    Vicente Estrada
    Hospital Clinico San Carlos, Madrid, Spain
    BMC Womens Health 11:36. 2011
    ..The objective of the study is to describe the lipid profile in a large cohort of HIV-infected women on contemporary ART and analyse differences between regimes and patient's characteristics...
  4. ncbi request reprint Dyslipidemia related to antiretroviral therapy
    Vicente Estrada
    Department of Infectious Diseases, Hospital Clinico San Carlos, Madrid, Spain
    AIDS Rev 13:49-56. 2011
    ..The current recommendations for dyslipidemia management include the control of other cardiovascular risk factors, the choice of antiretroviral drugs with a better lipid profile, and lipid-lowering drug use when clinically indicated...
  5. doi request reprint [Etravirine drug interactions]
    Vicente Estrada Pérez
    Hospital Clinico San Carlos, Madrid, Espana
    Enferm Infecc Microbiol Clin 27:27-31. 2009
    ..Interaction with fosamprenavir/ritonavir is not clinically significant, although their plasma levels vary slightly when used in combination with ETR. ETR shows no interactions with darunavir/ritonavir...
  6. doi request reprint [Clinical factors and biomarkers associated with subclinical atherosclerosis in the human immunodeficiency virus infection]
    Sergio Serrano-Villar
    Servicio de Medicina Interna III, Hospital Clinico San Carlos, Madrid, Espana
    Med Clin (Barc) 139:231-7. 2012
    ..We aimed to identify biomarkers and clinical factors associated with subclinical atherosclerosis in HIV-infected patients...
  7. ncbi request reprint Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study
    Matilde Sanchez-Conde
    Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain
    AIDS Res Hum Retroviruses 23:1237-41. 2007
    ..Its efficacy does not seem to be compromised when ddI is administered with food. Therefore, this regimen merits further investigation in larger comparative trials...
  8. doi request reprint Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms
    Sergio Serrano-Villar
    Department of Internal Medicine, Hospital Clinico San Carlos, Madrid, Spain
    Eur J Prev Cardiol 21:739-48. 2014
    ..We aimed to compare the agreement and diagnostic performance of Framingham, SCORE and D:A:D equations for the recognition of subclinical atherosclerosis in HIV patients and to adjust the D:A:D equation using HIV and CVD variables...
  9. ncbi request reprint Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy
    Vicente Estrada
    Internal Medicine Department, Diabetes and Lipids Research Laboratory, Hospital Clinico San Carlos, Complutense University, 28040 Madrid, Spain
    Metabolism 55:940-5. 2006
    ..In conclusion, the prevalence of metabolic syndrome is significantly increased in HIV-infected patients on ART and its presence is associated with lipo, increased age and BMI, IR, and a reduced plasma AD-to-leptin ratio...
  10. doi request reprint Association of HIV-Infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosis
    Dulcenombre Gomez-Garre
    Vascular Biology Research Laboratory, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos IdISSC, Madrid, Spain
    J Acquir Immune Defic Syndr 61:545-51. 2012
    ..We herein investigated the number of progenitor cell subpopulations in HIV-infected patients and its relationship to carotid intima-media thickness (c-IMT)...
  11. ncbi request reprint Disorders of body fat distribution in HIV-1-infected patients
    Santiago Moreno
    Hospital Ramon y Cajal, Madrid, Spain
    AIDS Rev 11:126-34. 2009
    ..Neither the interruption of antiretroviral therapy nor the use of metformin, glitazones or growth hormone analogs can be recommended due to their limited efficacy or associated complications...
  12. pmc Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients
    Ana Barrios
    Service of Infectious Diseases, Instituto de Salud Carlos III, Madrid, Spain
    J Clin Microbiol 41:4421-3. 2003
    ..Only five (3.7%) patients discontinued TDF use due to adverse events. In the multivariate analysis, the presence of M41L and/or L210W at baseline was the only viral determinant of a lower response to TDF...
  13. ncbi request reprint Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression
    Federico Pulido
    Unidad VIH, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain
    Antivir Ther 14:195-201. 2009
    ..Risk factors for loss of virological response in patients receiving lopinavir/ritonavir (LPV/r) monotherapy as maintenance treatment have not been determined...
  14. doi request reprint The future of antiretroviral therapy: challenges and needs
    Santiago Moreno
    Department of Infectious Diseases, Hospital Ramon y Cajal, Carretera de Colmenar Km 9 100, 28034 Madrid, Spain
    J Antimicrob Chemother 65:827-35. 2010
    ..This document summarizes the group's conclusions on the future of antiretroviral treatment, presented as 20 relevant questions. Each question includes the current status of the topic and our vision for the future...
  15. ncbi request reprint Vitamin D deficiency and vitamin D therapy in chronic hepatitis C
    Jose M Ladero
    Service of Gastroenterology, Hospital Clinico San Carlos, Department of Medicine, Medical School, Universidad Complutense, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos IdISSC, Madrid, Spain
    Ann Hepatol 12:199-204. 2013
    ....
  16. ncbi request reprint Long-term efficacy and safety of protease inhibitor switching to nevirapine in HIV-infected patients with undetectable virus load
    Paloma Gil
    Division of Infectious Diseases, Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain
    Clin Infect Dis 39:1024-9. 2004
    ..However, the long-term efficacy of HAART has not been properly assessed...
  17. doi request reprint [Stroke in the very old: myths and realities]
    Sergio Serrano-Villar
    Servicio de Medicina Interna III, Hospital Clinico San Carlos, Madrid, Espana
    Med Clin (Barc) 140:53-8. 2013
    ..The incidence of stroke in the very old is increasing. However, there are very few data regarding the differences in the management and outcomes in Spain...
  18. doi request reprint Incipient renal impairment as a predictor of subclinical atherosclerosis in HIV-infected patients
    Sergio Serrano-Villar
    Internal Medicine Department, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain
    J Acquir Immune Defic Syndr 59:141-8. 2012
    ..We assessed the relationship between incipient renal impairment (IRI) and subclinical atherosclerosis in HIV-infected patients...
  19. doi request reprint Functionally defective high-density lipoproteins are related to heightened T-cell activation in vertically HIV-infected adolescents
    Talía Sainz
    Laboratorio de Inmunobiologia Molecular, Department of Pediatrics, Instituto de Investigación Sanitaria Hospital General Universitario Gregorio Marañón IiSGM, Servicio de Pediatría e Instituto de Investigación Sanitaria Hospital Gregorio Marañón, Madrid, Spain Laboratorio de Vascular, Hospital Clinico San Carlos, Instituto de Investigacíon Sanitaria San Carlos IdISSC, Madrid, Spain Department of Infectious Diseases, Servicio de Enfermedades Infecciosas e IRYCIS, Hospital Universitario Ramon y Cajal, and IRYCIS, Madrid, Spain Department of Pediatrics, Servicio de Pediatria, Hospital General Universitario Gregorio Maranon, Madrid, Spain Department of Pediatrics, Unidad de Inmunodeficiencias pediátricas, Servicio de Pediatria, Hospital Universitario Doce de Octubre, Madrid, Spain Department of Pediatrics, Servicio de Pediatria, Hospital de Getafe, Madrid, Spain Department of Pediatrics, Servicio de Pediatria, Hospital Carlos III, Madrid, Spain Department of Internal Medicine, Servicio de Medicina Interna, Hospital Clinico San Carlos, Madrid, Spain and Networking Research Center on Bioengineering, Biomaterials and Nanomedicine CIBER BBN, Madrid, Spain
    J Acquir Immune Defic Syndr 66:265-9. 2014
    ..044), lower CD4 nadir (P = 0.043), increased levels of CD4 T-cell activation (P = 0.018), higher C-reactive protein (P = 0.009), and a tendency toward thicker carotid intima-media thickness (P = 0.071)...
  20. pmc Comparison of oxidative stress markers in HIV-infected patients on efavirenz or atazanavir/ritonavir-based therapy
    Vicente Estrada
    Infectious Diseases, Hospital Clinico San Carlos, Madrid, Spain
    J Int AIDS Soc 17:19544. 2014
    ..Atazanavir (ATV) inhibits UGT1A1, thus increasing unconjugated BR levels, a distinctive feature of this drug. We compared changes in OS markers in HIV patients on ATV/r versus efavirenz (EFV)-based first-line therapies...
  21. pmc Efficacy of a dual therapy based on darunavir/ritonavir and etravirine in ART-experienced patients
    Jose Ignacio Bernardino
    HIV Unit, Internal Medicine, Hospital La Paz, IdiPAZ, Madrid, Spain
    J Int AIDS Soc 17:19787. 2014
    ..NRTI-sparing regimens may be an option in patients with toxicities and for simplification reasons...
  22. doi request reprint Peak bone mass in young HIV-infected patients compared with healthy controls
    Eugenia Negredo
    Lluita contra la SIDA Foundation, Internal Medicine Department, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain Internal Medicine Department, Hospital Sant Pau, Barcelona, Spain Internal Medicine Department, Hospital Bellvitge, Barcelona, Spain Internal Medicine Department, Hospital Clinico San Carlos, Madrid, Spain Internal Medicine Department, Hospital Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain CETIR, Grup Mèdic, Barcelona, Spain Statistics and Operations Research, Technical University of Catalunya, Barcelona, Spain and IrsiCaixa Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain
    J Acquir Immune Defic Syndr 65:207-12. 2014
    ..Peak bone mass (PBM) is the amount of bone present at the end of skeletal maturation. It is an important determinant of osteoporotic fracture risk. Data on the PBM in the HIV-infected population are lacking...
  23. ncbi request reprint [Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection]
    Rosa Polo
    Consejera Técnica, Plan Nacional sobre el Sida, Madrid, Espana
    Enferm Infecc Microbiol Clin 24:96-117. 2006
    ..To provide an update of the metabolic and morphologic alterations in patients infected with HIV with an in-depth analysis of their clinical management and treatment...
  24. doi request reprint Prevalence and impact of body physical changes in HIV patients treated with highly active antiretroviral therapy: results from a study on patient and physician perceptions
    Esther Cabrero
    Medical Department, Abbott Laboratories, Avenida de Burgos 91, Madrid, Spain
    AIDS Patient Care STDS 24:5-13. 2010
    ..Physicians should be aware of the psychosocial consequences of BPC in HIV patients in order to improve patient well-being...
  25. pmc Lp-PLA2 levels in HIV-infected patients
    Beatriz Díaz-Pollán
    Medicina Interna, Hospital Universitario La Paz, Madrid, Spain
    J Int AIDS Soc 17:19721. 2014
    ..In the general population, lipoprotein-associated phospholipase A2 (Lp-PLA2) appears to be an independent predictor of CVD. We aimed to study associations between Lp-PLA2 plasma levels and other risk factors for CVD in HIV patients...
  26. ncbi request reprint Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy
    Vicente Estrada
    Department of Internal Medicine, Hospital Clinico San Carlos, Madrid, Spain
    J Acquir Immune Defic Syndr 29:32-40. 2002
    ..In patients with predominant loss of fat, the roles of leptin, lipids, and glucose homeostasis disturbances have not yet been clearly established...
  27. ncbi request reprint Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages
    Mariola Lopez
    Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain
    AIDS Rev 14:223-30. 2012
    ..The potential usefulness of measuring cardiovascular disease risk biomarkers in HIV-infected individuals to prevent future cardiovascular events is further discussed...